About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
New Injectable Form of Cabotegravir Drug To Prevent HIV
Advertisement

New Injectable Form of Cabotegravir Drug To Prevent HIV

Font : A-A+

Highlights
  • Injectable form of cabotegravir drug is being tested to prevent HIV transmission.
  • Pre-exposure prophylaxis (PrEP) drug when taken daily can be difficult for some people.
  • Cabotegravir drug is found to be long-acting and effective when taken once every eight weeks.

The first human clinical trials for an injectable form of cabotegravir drug is being tested to prevent the transmission of HIV virus.

The injectable form of the drug is found to be long-acting when compared to the daily PrEP (pre-exposure prophylaxis) regimen.

Advertisement


The injection is administered once every eight weeks and is found to be effective when compared to a once daily pill called Truvada (emtricitabine and tenofovir disoproxil fumarate).

The research study was conducted on 4500 men who have sex with men, and transgender women who have sex with men. The people who took part in the study were above the age of 18years and were at a higher risk of HIV infections. They were from eight different countries including America, Asia and Africa.
Advertisement

The research team investigated the effect of cabotegravir injection in HIV prevention when compared to the oral form of Truvada.

Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said, "We urgently need more HIV prevention tools that fit easily into people's lives."

"Although daily oral Truvada clearly works for HIV prevention, taking a daily pill while feeling healthy can be difficult for some people.

"If proven effective, injectable cabotegravir has the potential to become an acceptable, discreet and convenient alternative for HIV prevention."

According to the News Medical Life Sciences, the results of the drug trial are not expected to be known for atleast five years. However, if found to be successful, the drug will be effective to be taken once every eight weeks.

Human Immunodeficiency Virus (HIV)
Human immunodeficiency virus (HIV) is a retrovirus which causes AIDS (Acquired Immunodeficiency Syndrome).

Pre-Exposure Prophylaxis (PrEP)
People who are at a high risk of HIV take PrEP medicines everyday to lower their chances of getting the infection.

A combination of tenofovir and emtricitabine is taken as a single pill daily under the name Truvada to prevent transmission of HIV.

References
  1. PrEP - (https://www.cdc.gov/hiv/basics/prep.html)


Source: Medindia

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Madhumathi Palaniappan. (2016, December 30). New Injectable Form of Cabotegravir Drug To Prevent HIV. Medindia. Retrieved on Sep 28, 2022 from https://www.medindia.net/news/healthwatch/new-injectable-form-of-cabotegravir-drug-to-prevent-hiv-166589-1.htm.

  • MLA

    Madhumathi Palaniappan. "New Injectable Form of Cabotegravir Drug To Prevent HIV". Medindia. Sep 28, 2022. <https://www.medindia.net/news/healthwatch/new-injectable-form-of-cabotegravir-drug-to-prevent-hiv-166589-1.htm>.

  • Chicago

    Madhumathi Palaniappan. "New Injectable Form of Cabotegravir Drug To Prevent HIV". Medindia. https://www.medindia.net/news/healthwatch/new-injectable-form-of-cabotegravir-drug-to-prevent-hiv-166589-1.htm. (accessed Sep 28, 2022).

  • Harvard

    Madhumathi Palaniappan. 2021. New Injectable Form of Cabotegravir Drug To Prevent HIV. Medindia, viewed Sep 28, 2022, https://www.medindia.net/news/healthwatch/new-injectable-form-of-cabotegravir-drug-to-prevent-hiv-166589-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

Most Popular on Medindia

Indian Medical Journals The Essence of Yoga Daily Calorie Requirements Iron Intake Calculator Blood - Sugar Chart Noscaphene (Noscapine) Drug Interaction Checker Diaphragmatic Hernia A-Z Drug Brands in India Drug - Food Interactions
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

New Injectable Form of Cabotegravir Drug To Prevent HIV Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests